Risk Factors for CMV Viremia and Treatment-Associated Adverse Events Among Pediatric Hematopoietic Stem Cell Transplant Recipients.
Sarah M HestonRebecca R YoungJohn S TanakaKirsten JenkinsRichard VinesettFrances M SaccoccioPaul L MartinNelson J ChaoMatthew S KellyPublished in: Open forum infectious diseases (2021)
CMV viremia occurred commonly among children after HSCT, and ganciclovir and foscarnet were associated with distinct toxicity profiles among children with CMV infection. These findings should be considered when developing CMV prevention and treatment strategies for children after HSCT.
Keyphrases